F-star Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2015 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
F-star Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2021.
  • F-star Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$13.7M, a 42.8% decline year-over-year.
  • F-star Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$36.8M, a 16.5% increase year-over-year.
  • F-star Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$30.7M, a 37.2% decline from 2020.
  • F-star Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$22.4M, a 0.5% increase from 2019.
  • F-star Therapeutics, Inc. annual Operating Income (Loss) for 2019 was -$22.5M, a 21% increase from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$30.7M -$8.33M -37.2% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-15
2020 -$22.4M +$112K +0.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$22.5M +$5.97M +21% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 -$28.5M -$7.22M -34% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-14
2017 -$21.3M -$1.85M -9.53% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-11
2016 -$19.4M -$7.81M -67.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-20
2015 -$11.6M Jan 1, 2015 Dec 31, 2015 10-K 2017-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.